Blog
Latest articles, insights, and updates from the blog.
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.
Ketamine Offers Fast Relief for Depression and Suicidal Thoughts
Medscape research confirms ketamine rapidly relieves depression and suicidal ideation. What it means for patients exploring online ketamine treatment.
Ketamine vs. TMS: Choosing the Right Depression Path
Medical Daily breaks down when ketamine or TMS is the right call for treatment-resistant depression and what patients can realistically expect.
New Trial: CBT After Esketamine Lowers Relapse Risk
CBT-ENDURE trial: pairing CBT with esketamine significantly reduces depression relapse and suicidal ideation. What online ketamine patients need to know.
CBT After Ketamine Cuts Relapse Risk, Trial Finds
The CBT-ENDURE trial shows adding 16 weeks of CBT after esketamine significantly improves outcomes for depression and suicidal ideation. What patients should know.
Your Antidepressant May Not Affect Ketamine Outcomes
New research finds concurrent antidepressant use doesn't significantly alter ketamine or esketamine outcomes — here's what that means for patients.
Ketamine Side Effects Data: What TRD Patients Need to Know
New clinical analysis urges smarter ketamine protocols for TRD—what side effect data and dropout rates mean for patients exploring online ketamine treatment.
What New NMDA Data Means for Ketamine Patients
New clinical guidance on NMDA receptor antagonists urges smarter dose optimization and faster switching. Here's what it means for online ketamine patients.
NMDA Antagonists for TRD: What the Data Means for You
New clinical data on NMDA receptor antagonists for TRD highlights side effect profiles, dropout rates, and why faster dose optimization matters for patients.
When Clinicians Switch Sooner: New TRD Dosing Guidance
New clinical guidance urges faster dose adjustments and PHQ-9 tracking for ketamine patients. Here's what it means for your online treatment.
Faster TRD Remission: What Smarter Dosing Means for You
New clinical guidance on treatment-resistant depression highlights why symptom tracking and dose flexibility matter—especially for online ketamine patients.
What Side Effect Data Means for Ketamine Patients
New research in Psychiatric Times breaks down side effect profiles and dropout rates for ketamine and esketamine. Here's what it means for your treatment decision.
Nitrous Oxide for Depression: What Patients Should Know
New research explores nitrous oxide for treatment-resistant depression. Here's how it compares to ketamine and what it means for patients seeking relief in 2026.
What New TRD Data Means for Ketamine Patients
New clinical guidance on NMDA receptor antagonists urges faster dose optimization and closer monitoring. Here's what it means for online ketamine treatment.